Implementing and Sustaining a Transdiagnostic Sleep and Circadian Treatment

April 19, 2019 updated by: University of California, Berkeley
The goal is to collect pilot data on an adapted version of the Transdiagnostic Sleep and Circadian intervention (TranS-C), referred to as 'Fitted TranS-C'.

Study Overview

Detailed Description

Mental illness is often severe, chronic and difficult to treat. The sleep disturbance commonly experienced by individuals with a severe mental illness reduces capacity to function and contributes to key symptoms. This study seeks to collect pilot data on an adapted version of the Transdiagnostic Sleep and Circadian intervention (TranS-C). The adapted version will be referred to as 'Fitted TranS-C' as it is designed to improve the fit to delivery within community mental health centers. 'Fitted' treatments are needed because the context for implementation (community setting) typically differs from the original testing context (university setting) causing a lack of 'fit' between the setting and evidence based treatments.

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Berkeley, California, United States, 94702
        • UC Berkeley

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Can understand treatment in English
  • Is not currently at risk for suicide or homicide
  • Has not worked the night shift more than 2 nights per week in the past 3 months
  • Is not pregnant or nursing
  • Has a guaranteed bed to sleep in for the next month, which is not a shelter.

Exclusion Criteria:

  • At risk for suicide or homicide
  • Has worked the night shift more than 2 nights per week in the past 3 months
  • Is pregnant or nursing
  • Does not have a guaranteed bed to sleep in for the next month

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Fitted TranS-C
Fitted TranS-C involves 4 x 20-30 minute sessions. It involves selected cross-cutting, core and optional modules from Standard TranS-C.
Fitted TranS-C is an adapted version is designed to improve the fit with community needs and resources.
Other Names:
  • Fitted TranS-C

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The acceptability of the intervention to providers will be assessed by the 'Acceptability of Intervention Measure' (AIM)
Time Frame: 4 weeks (i.e. post-treatment assessment)
The AIM is a measure of the extent to which the intervention is acceptable to providers. The AIM is comprised of 4 questions rated on a 1 'completely disagree' to 5 'completely agree' scale. The responses to all four qus will be reported along with the summed total score.
4 weeks (i.e. post-treatment assessment)
PROMIS--Sleep Disturbance (PROMIS = Patient-Reported Outcomes Information System)
Time Frame: Pre-treatment and 4 weeks later (i.e. post-treatment assessment)
Assesses sleep disturbance experienced by patients
Pre-treatment and 4 weeks later (i.e. post-treatment assessment)
CEQ (Treatment Evaluation Questionnaire)
Time Frame: 4 weeks (i.e. post-treatment assessment)
Assesses patients' expectations of the treatment.
4 weeks (i.e. post-treatment assessment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Process evaluation/qualitative interview
Time Frame: 4 weeks (i.e. post-treatment assessment)
Assessing the clients' and therapists' opinions of the treatment
4 weeks (i.e. post-treatment assessment)
MINI
Time Frame: Baseline only
Index of psychiatric disorders
Baseline only

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Referral form
Time Frame: Baseline only
Assesses participant suitability for the study
Baseline only

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 20, 2018

Primary Completion (ACTUAL)

December 1, 2018

Study Completion (ACTUAL)

December 1, 2018

Study Registration Dates

First Submitted

June 4, 2018

First Submitted That Met QC Criteria

June 4, 2018

First Posted (ACTUAL)

June 14, 2018

Study Record Updates

Last Update Posted (ACTUAL)

April 22, 2019

Last Update Submitted That Met QC Criteria

April 19, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Disorder

Clinical Trials on Fitted Transdiagnostic Sleep and Circadian intervention

3
Subscribe